subject area of
- Adverse events associated with nevirapine and efavirenz-based first-line antiretroviral therapy Journal Articles
- Comparative efficacy and safety of first-line antiretroviral therapy for the treatment of HIV infection: a systematic review and network meta-analysis Journal Articles
- Dithiafulvenyl-grafted phenylene ethynylene polymers as selective and reversible dispersants for single-walled carbon nanotubes Journal Articles
- Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals Journal Articles
- Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study Journal Articles
-
Fibroblast growth factor 23: associations with antiretroviral therapy in patients co‐infected with
HIV and hepatitis C Journal Articles - Histrionicotoxin: Effects on Some Central and Peripheral Excitable Cells Journal Articles
- Pharmacogenetic-Based Efavirenz Dose Modification: Suggestions for an African Population and the Different CYP2B6 Genotypes Journal Articles
- Phosphines Bearing Alkyne Substituents: Synthesis and Hydrophosphination Polymerization Journal Articles
- Properties of Poly(ethylene glycol) Hydrogels Cross-Linked via Strain-Promoted Alkyne–Azide Cycloaddition (SPAAC) Journal Articles
- Reproducible Dendronized PEG Hydrogels via SPAAC Cross-Linking Journal Articles
- Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials Journal Articles
- Safety of efavirenz in first-trimester of pregnancy: a systematic review and meta-analysis of outcomes from observational cohorts Journal Articles
- The First Well‐Defined Silver(I)‐Complex‐Catalyzed Cycloaddition of Azides onto Terminal Alkynes at Room Temperature Journal Articles
- Therapy with Efavirenz plus Indinavir in Patients with Extensive Prior Nucleoside Reverse‐Transcriptase Inhibitor Experience: A Randomized, Double‐Blind, Placebo‐Controlled Trial Journal Articles